Home » Takeda and Orexigen Launch Weight Management Drug Contrave in U.S.
Takeda and Orexigen Launch Weight Management Drug Contrave in U.S.
Takeda Pharmaceutical and Orexigen Therapeutics have launched Contrave (naltrexone HCI and bupropion HCI) extended-release tablets in the U.S. and will be available to patients by prescription.
Pharmaceutical Business Review
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May